CG Oncology, Inc. share price logo

CG Oncology, Inc.

NASDAQ: CGON

Mid Cap

$67.15

-1.61

(-2.34%)

as on

CG Oncology, Inc. Stock Performance

as on September 26, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $66.76
    $70.05
    downward going graph

    0.58%

    Downside

    4.32%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $35.64
    $80.97
    downward going graph

    46.92%

    Downside

    20.58%

    Upside

    downward going graph

CG Oncology, Inc. share price movements today

Previous Close
$68.76
Open
$69.25
Volume
602.7K
Market Cap
$6.9B
Day's Low - High
$66.76 - $70.05
52 Week Low - High
$35.64 - $80.97

CG Oncology, Inc. Historical Returns

1 Month Return
-6.23 %
3 Month Return
+ 6.75 %
1 Year Return
+ 100 %
3 Year Return
0 %
5 Year Return
0 %

CG Oncology, Inc. Stock Fundamentals & Key Indicators

Check CG Oncology, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.9B

EPS (TTM)

-2.7

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-28.79

Industry PE ratio

-13.64

PEG Ratio

0.7554883764928392

EBITDA

-222.3M

Revenue (TTM)

6.2M

Profit Margin

-82.69%

Return On Equity TTM

-25.20%

CG Oncology, Inc. Stock Valuation

Track how CG Oncology, Inc. P/E has moved over time to understand its valuation trends.

CG Oncology, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-192.92x)

December 31, 2021

Today (-19.96x)

December 31, 2025

Industry (-13.64x)

December 31, 2025

Highest (-19.96x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -19.96x

CG Oncology, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CG Oncology, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
CG Oncology, Inc. image
CG Oncology, Inc.
StrongBuy$6.9BNA-28.79-82.69%0.00%
Moderna image
Moderna
Neutral$77.8B-53.76%-24.41-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.4B186.58%30.1686.04%0.00%
Regeneron image
Regeneron
Buy$82.8B23.34%19.0184.86%0.46%

Stock Returns calculator for CG Oncology, Inc. Stock including INR - Dollar returns

The CG Oncology, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

CG Oncology, Inc. investment value today

Current value as on today

₹1,97,599

Returns

₹97,599

(+97.6%)

Returns from CG Oncology, Inc. Stock

₹83,070 (+83.07%)

Dollar Impact

₹14,529 (+14.53%)

Analyst Recommendation on CG Oncology, Inc. Stock

Based on 9 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for CG Oncology, Inc.. Average target price of $91.08

CG Oncology, Inc. Share Price Target

Get share price movements and forecasts by analysts on CG Oncology, Inc..

What analysts predicted

26.27%UPSIDE

Target Price

$91.08

Current Price

$67.15

Analyzed by

9 Analysts

High

$108

Target

$91.08

Low

$79

CG Oncology, Inc. target price $91.08, a slight upside of 26.27% compared to current price of $67.15. According to 9 analysts rating.

Indian Investors' Interest in CG Oncology, Inc. Stock

Search interest for CG Oncology, Inc. Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

CG Oncology, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
-
1
2
1
1
Gross Profit
0
-18
-19
-26
-27
-31
0
0
-1
-2
Operating Income
-22
-25
-28
-38
-42
-48
-51
-48
-66
-86
EBITDA
-16
-18
-20
-31
-34
-41
-43
-40
-59
-79
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
-
0
0
0
0
0
-
Income Before Tax
-16
-18
-20
-31
-34
-41
-43
-41
-60
-79
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-16
-18
-20
-31
-34
-41
-43
-41
-60
-79
Net Profit Margin
99.24%
100.00%
100.00%
100.00%
-52721.15%
0.00%
5.34%
-25.50%
-173.50%
-239.24%

CG Oncology, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
10
0
0
1
4
Gross Profit
10
0
-45
-80
0
Operating Income
-12
-35
-55
-114
-190
EBITDA
-12
-35
-48
-88
-159
Interest Expense
0
0
-
-
-
Depreciation
0
0
0
0
1
Income Before Tax
-12
-35
-48
-88
-160
Income Tax Expense
-
-
-
-
-
Net Income
-12
-35
-48
-88
-160
Net Profit Margin
99.90%
92.15%
100.00%
100.00%
-15.02%

CG Oncology, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
-18
-20
-31
-34
-41
-43
-41
-60
-79
Operating Cash Flow
-26
-16
-15
-20
-29
-27
-38
-36
-56
-46
Investing Cash Flow
-307
-36
32
10
-186
1
15
-75
-334
30
Financing Cash Flow
402
0
2
223
0
0
54
99
392
1
Change in Cash
69
-52
18
213
-215
-26
30
-12
1
-14

CG Oncology, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-35
-48
-88
-160
Operating Cash Flow
-13
-29
-45
-78
-132
Investing Cash Flow
0
-55
-121
-300
-245
Financing Cash Flow
15
119
86
628
153
Change in Cash
1
34
-79
248
-224

Mutual Funds that own CG Oncology, Inc. Stock

Check out the Mutual Funds with significant holdings in CG Oncology, Inc..

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
6.257522%
5546691
VANGUARD SPECIALIZED FUNDS
2.92107%
2589248
T. ROWE PRICE CAPITAL APPRECIATION FUND, INC.
2.904847%
2574868
Fidelity Securities Fund
1.517011%
1344685
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
1.250641%
1108573
See all

Global Institutional Holdings in CG Oncology, Inc.

Funds
Holdings
Vanguard
7.59%
VANGUARD INDEX FUNDS
6.26%
iShares
3.96%
VANGUARD SPECIALIZED FUNDS
2.92%
T. ROWE PRICE CAPITAL APPRECIATION FUND, INC.
2.9%
See all

Insights on CG Oncology, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 633.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CGON stock has moved down by -10.0%

About CG Oncology, Inc.

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent; phase 3 BOND-003 Cohort P as a single agent in patients with BCG-UR papillary-only NMIBC. It also develops cretostimogene monotherapy for intermediate-risk NMIBC following TURBT, which is in phase 3 PIVOT-006 clinical trials to assess the safety and efficacy of adjuvant cretostimogene; and cretostimogene monotherapy for high-risk NMIBC in phase 2 CORE-008 clinical trials to assess the safety and clinical outcomes of cretostimogene in treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC. The company was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is headquartered in Irvine, California.
OrganisationCG Oncology, Inc.
Headquarters3000 Pegasus Park Drive, Dallas, TX, 75247, US
IndustryBiotechnology
CEOArthur Kuan
E-voting on sharesClick here to vote

Key Management of CG Oncology, Inc.

Name

Title

Ms. Sarah Connors

Vice President of Communications & Patient Advocacy

Mr. Bing Kung

Vice President of Corporate Development

Mr. Arthur Kuan

President, Chairman & CEO

Mr. James M. DeTore

Chief Financial Officer

Mr. Joshua F. Patterson

General Counsel, Chief Compliance Officer & Secretary

Dr. Vijay Kasturi M.D.

Chief Medical Officer

Mr. Swapnil Bhargava Ph.D.

Chief Technical Officer

Ms. Amy Steele

Vice President of Finance & Administration

FAQs

What is CG Oncology, Inc. share price today?

CG Oncology, Inc. share price today is $67.15 as on at the close of the market. CG Oncology, Inc. share today touched a day high of $70.05 and a low of $66.76.

What is the 52 week high and 52 week low for CG Oncology, Inc. share?

CG Oncology, Inc. share touched a 52 week high of $80.97 on and a 52 week low of $35.64 on . CG Oncology, Inc. stock price today i.e. is closed at $67.15,which is 17.07% down from its 52 week high and 88.41% up from its 52 week low.

What is CG Oncology, Inc.'s market capitalisation today?

CG Oncology, Inc. market capitalisation is $0.01T as on .

How to invest in CG Oncology, Inc. Stock (CGON) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for CG Oncology, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CG Oncology, Inc. Shares that will get you 0.0223 shares as per CG Oncology, Inc. share price of $67.15 per share as on September 26, 2026 at 8:46 am IST.

What is the minimum amount required to buy CG Oncology, Inc. Stock (CGON) from India?

Indian investors can start investing in CG Oncology, Inc. (CGON) shares with as little as ₹95.8125 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in CG Oncology, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on CG Oncology, Inc. share’s latest price of $67.15 as on September 26, 2026 at 8:46 am IST, you will get 0.1489 shares of CG Oncology, Inc.. Learn more about fractional shares .